My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1102

    1.

    Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

    Ann Intern Med. 2003 May 6;138(9):705-13.PMID: 12729424 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.

    Winston DJ, Busuttil RW.

    Transplantation. 2002 Sep 15;74(5):688-95.PMID: 12352887 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.

    Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S.

    Bone Marrow Transplant. 2000 Apr;25(8):853-9.PMID: 10808206 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.

    Winston DJ, Pakrasi A, Busuttil RW.

    Ann Intern Med. 1999 Nov 16;131(10):729-37.PMID: 10577295 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.

    Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K; Itraconazole Neutropenia Study Group.

    Ann Intern Med. 2001 Sep 18;135(6):412-22.PMID: 11560454 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.

    Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M, Liso V, Nosari AM, Barbui T, Fasola G, Mandelli F; GIMEMA Infection Program.

    Ann Intern Med. 1994 Jun 1;120(11):913-8.PMID: 8172437 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

    Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S.

    N Engl J Med. 2007 Jan 25;356(4):335-47. Erratum in: N Engl J Med. 2007 Jul 26;357(4):428. PMID: 17251530 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Summaries for patients. Preventing fungal infections in patients with stem-cell transplants.

    [No authors listed]

    Ann Intern Med. 2003 May 6;138(9):I37. No abstract available. PMID: 12729449 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.

    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.

    Cancer. 2003 Jan 15;97(2):450-6.PMID: 12518369 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

    Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN.

    Ann Intern Med. 1993 Apr 1;118(7):495-503.PMID: 8442620 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.

    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.

    Am J Hematol. 2002 Dec;71(4):260-7.PMID: 12447954 [PubMed - indexed for MEDLINE]Related articles

    12.

    Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

    Harousseau JL, Dekker AW, Stamatoullas-Bastard A, Fassas A, Linkesch W, Gouveia J, De Bock R, Rovira M, Seifert WF, Joosen H, Peeters M, De Beule K.

    Antimicrob Agents Chemother. 2000 Jul;44(7):1887-93.PMID: 10858349 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.

    N Engl J Med. 2007 Jan 25;356(4):348-59.PMID: 17251531 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.

    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

    Bone Marrow Transplant. 2006 Jul;38(2):127-34. Epub 2006 Jun 5.PMID: 16751782 [PubMed - indexed for MEDLINE]Related articles

    15.

    Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.

    Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA, Nichols WG, Musher B, Corey L.

    Blood. 2004 Feb 15;103(4):1527-33. Epub 2003 Oct 2.PMID: 14525770 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

    Huijgens PC, Simoons-Smit AM, van Loenen AC, Prooy E, van Tinteren H, Ossenkoppele GJ, Jonkhoff AR.

    J Clin Pathol. 1999 May;52(5):376-80.PMID: 10560360 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Posaconazole: an extended-spectrum triazole antifungal agent.

    Schiller DS, Fung HB.

    Clin Ther. 2007 Sep;29(9):1862-86. Review.PMID: 18035188 [PubMed - indexed for MEDLINE]Related articles

    18.

    An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H; Itraconazole Research Group of Germany.

    J Antimicrob Chemother. 2006 Feb;57(2):317-25. Epub 2005 Dec 8.PMID: 16339606 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Role of new antifungal agents in prophylaxis of mycoses in high risk patients.

    van Burik JA.

    Curr Opin Infect Dis. 2005 Dec;18(6):479-83. Review.PMID: 16258319 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.

    Krishna G, Martinho M, Chandrasekar P, Ullmann AJ, Patino H.

    Pharmacotherapy. 2007 Dec;27(12):1627-36.PMID: 18041883 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity